• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AdvisorShares Psychedelics ETF (NY:PSIL)

16.77 -0.12 (-0.70%)
Official Closing Price Updated: 8:00 PM EDT, Mar 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,530
Open 16.94
Bid (Size) 16.01 (100)
Ask (Size) 16.83 (100)
Prev. Close 16.89
Today's Range 16.77 - 16.94
52wk Range 9.580 - 21.61
Shares Outstanding 7,499
Dividend Yield 40.16%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
RLMD Stock Soars Pre-Market: Phase 2 Bladder Cancer Trial Data Impresses Investors ↗
March 09, 2026
Relmada stated that the therapy showed a 76% complete response rate at 12 months in high-risk non-muscle invasive bladder cancer. 
Via Stocktwits
News headline image
Enveric Biosciences Announces Withdrawal Of Petition Against Its Patent — ENVB Stock Rises ↗
February 25, 2026
The company stated that, following the withdrawal of Gilgamesh’s challenge, there are no remaining challenges against its patent. 
Via Stocktwits
Topics Intellectual Property

Performance

YTD
-2.5%
-2.5%
1 Month
-0.8%
-0.8%
3 Month
-14.3%
-14.3%
6 Month
-3.8%
-3.8%
1 Year
+34.1%
+34.1%

More News

Read More
News headline image
HELP Stock Rallies After Experimental Depression Drug Reduces Symptoms In Study: Retail Thinks Its ‘Time To Buy More’ ↗
February 17, 2026
Via Stocktwits
News headline image
CMPS Stock Rises 23% Pre-Market As Compass Achieves Primary Endpoint In Phase 3 Treatment-Resistant Depression Trial ↗
February 17, 2026
Via Stocktwits
NEUP Shares Rise Pre-Market As It Explores Strategic Alternatives, Including Potential Acquisition ↗
November 11, 2025
Via Stocktwits
News headline image
CMPS Stock Jumps 22% Pre-Market As Compass Sets Timeline For New Phase 3 Depression Trial Results ↗
February 17, 2026
Via Stocktwits
News headline image
Psychedelics Break Out Of The Fringe Under RFK Jr’s 2025 Reset — But Did MNMD Or CMPS Own The Year? ↗
December 24, 2025
Via Stocktwits
Topics ETFs
News headline image
Optimism Flows From Pot To Psychedelics: Atai Beckley, Supernus Stocks Rise After Analyst Flags Positive Tailwinds From Trump’s Marijuana Order ↗
December 19, 2025
Via Stocktwits
Topics Cannabis ETFs Government
News headline image
Why Did KTTA Stock Soar A Whopping 48% Today? ↗
November 28, 2025
Via Stocktwits
News headline image
Quantum Biopharma Reports Positive Phase 1 Safety For Multiple Sclerosis Drug ↗
August 05, 2025
Via Benzinga
News headline image
Compass Pathways Stock Slumps After Positive Late-Stage Trial Results From Psychedelic Drug ‘Underwhelm’ Analysts ↗
June 23, 2025
Via Stocktwits
News headline image
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors ↗
May 24, 2025
Via Benzinga
Topics Government
News headline image
5 ETFs That Beat Market Turmoil With Gains Last Week ↗
February 10, 2025
Via Benzinga
Topics ETFs Economy
News headline image
High-Momentum ETFs Leading the Market This Year
February 07, 2025
Via MarketBeat
Topics ETFs
News headline image
Small-Cap NRx Pharma’s Stock Draws Heavy Retail Buzz After Securing $27M Funding ↗
January 29, 2025
Via Stocktwits
News headline image
Mind Medicine Stock Rises As Evercore Projects 200% Upside On LSD Formulation: Retail Turns Bullish ↗
January 28, 2025
Via Stocktwits
News headline image
5 Best-Performing Sector ETFs Of Q4 ↗
January 02, 2025
Via Talk Markets
Topics ETFs
News headline image
Why Is Penny Stock Clearmind Gaining Today? ↗
December 24, 2024
Via Benzinga
News headline image
5 Best-Performing Sector ETFs Midway In Q4 ↗
November 16, 2024
Via Talk Markets
Topics ETFs
News headline image
Top And Flop ETFs Of The First Half ↗
June 29, 2024
Via Talk Markets
Topics ETFs
News headline image
Best And Worst ETF Zones Of Q2 ↗
June 26, 2024
Via Talk Markets
Topics Artificial Intelligence ETFs Economy
News headline image
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment ↗
June 05, 2024
Via Benzinga
News headline image
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More ↗
April 17, 2024
Via Benzinga
News headline image
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence ↗
March 29, 2024
Via Benzinga
News headline image
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More ↗
March 20, 2024
Via Benzinga
Topics Economy

Frequently Asked Questions

Is AdvisorShares Psychedelics ETF publicly traded?
Yes, AdvisorShares Psychedelics ETF is publicly traded.
What exchange does AdvisorShares Psychedelics ETF trade on?
AdvisorShares Psychedelics ETF trades on the New York Stock Exchange
What is the ticker symbol for AdvisorShares Psychedelics ETF?
The ticker symbol for AdvisorShares Psychedelics ETF is PSIL on the New York Stock Exchange
What is the current price of AdvisorShares Psychedelics ETF?
The current price of AdvisorShares Psychedelics ETF is 16.77
When was AdvisorShares Psychedelics ETF last traded?
The last trade of AdvisorShares Psychedelics ETF was at 03/17/26 08:00 PM ET
What is the market capitalization of AdvisorShares Psychedelics ETF?
The market capitalization of AdvisorShares Psychedelics ETF is 125.77K
How many shares of AdvisorShares Psychedelics ETF are outstanding?
AdvisorShares Psychedelics ETF has 126K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap